Skip to main content

Table 1 General demographic, clinical and neuropathological characteristics of the subjects included in this study

From: Mixed pathologies in pancreatic β cells from subjects with neurodegenerative diseases and their interaction with prion protein

Groups Number of cases Male/Female Age (years) PMD (hours)
Subjects with a normal neuropathological examination 27 19/8 70 (65–75) 6 (3–8)
Subjects with a normal neuropathological examination and T2DM 19 11/8 lg 6 (4–8)
AD with low neuropathologic change 28 14/14 77 (73–81) 6 (4–8)
AD with intermediate neuropathologic change 26 11/15 78 (75–82) 5 (4–6)
AD with high neuropathologic change 8 3/5 83 (76–92) 5 (3–6)
Incidental Lewy body disease 8 7/1 71 (66–76) 7 (6–8)
Parkinson's disease 10 5/5 77 (74–82) 6 (5–8)
Dementia with Lewy bodies 12 9/3 82 (76–88) 6 (5–8)
  1. The data are the median (25th/75th percentiles) or n (%): PD, Parkinson’s disease; DLB, dementia with Lewy bodies; ILBD, incidental Lewy body disease; AD, Alzheimer’s disease; T2DM, type two diabetes mellitus; PMD, postmortem delay